A week after signing a lucrative licensing agreement, the top management at Ann Arbor-based pharmaceutical startup Evoq Therapeutics Inc. gets replaced. The company announced last week that public biopharmaceutical conglomerate Gilead Sciences Inc. would license its rheumatoid arthritis and lupus…